- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 284 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2024
- 147 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 133 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- May 2024
- 181 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2021
- 295 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- November 2022
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- March 2023
- 114 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 112 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- August 2022
- 109 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- November 2022
- 226 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- November 2022
- 82 Pages
Asia Pacific
From €1365EUR$1,500USD£1,170GBP
- Report
- November 2022
- 71 Pages
North America
From €1365EUR$1,500USD£1,170GBP

Clotrimazole is an antifungal drug used to treat a variety of infectious diseases caused by fungi. It is commonly used to treat skin infections such as athlete's foot, jock itch, and ringworm, as well as vaginal yeast infections. It is also used to treat fungal infections of the mouth, throat, and lungs. Clotrimazole works by inhibiting the growth of fungi, preventing them from spreading and causing infection.
The clotrimazole market is a rapidly growing segment of the infectious diseases drugs market. It is widely used in both the developed and developing world, and is available in both prescription and over-the-counter forms. The drug is well-tolerated and has a low risk of side effects, making it an attractive option for treating fungal infections.
Some of the major companies in the clotrimazole market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Bayer. These companies produce a variety of clotrimazole-based products, ranging from creams and ointments to tablets and capsules. Show Less Read more